Osteoarthritis
Conditions
Keywords
Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis
Brief summary
The aim of this study is to evaluate the effectiveness of a complex āyurvedic diagnosis and treatment compared to conventional standard care in patients with OA of the knee.
Interventions
OTHERComplex Ayurvedic Treatment
In the Āyurveda group treatment will be individualized according to the Āyurveda diagnosis and include manual treatments, massages, dietary advice, specific consideration of selected food items, nutritional supplements, āyurvedic lifestyle and yoga posture advice and daily self-applied knee massage.
OTHERConventional Care
Patients in the conventional standard care group will receive conventional standard care for OA of the Knee which includes self care advice, pain medication and intensified physiotherapy and follows the current international guidelines for OA of the knee.
Sponsors
Ministry of Health & Family Welfare, India
Charite University, Berlin, Germany
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Male and female patients, * Age 40-70 years, * Prediagnosed, confirmed and documented diagnosis of OA of the knee. Diagnosis performed by a medical specialist (orthopedic surgeon, surgeon, radiologist) according to the American College of Rheumatology criteria, * Documented radiologic changes of the knee-joint Kellgren-Lawrence criteria \> or = grade 2 in conventional X-ray or MRI-scan, * Mean average pain intensity of 40 or more on two 100 mm visual analogue scales in the 7 days before baseline assessment, * Written informed consent.
Exclusion criteria
* Pain in the knee caused by oCongenital dysplasia of the affected knee oRheumatoid arthritis oAutoimmune diseases oMalignancies oStatus post Knee surgery oStatus post Arthroscopy * Administration of chondroprotective drugs in the preceding 3 months, * Intra-articular injection into the affected knee-joint during the preceding 3 months, * Beginning of a systemic medication with corticosteroids within the preceding three months, * Beginning of any new treatment for OA during the previous 4 weeks (with the exception of analgesic treatment with Paracetamol or NSAIDs), * Pregnancy or breastfeeding, * Acute mental disorders, * Serious acute organic diseases, * Serious chronic co-morbidity, * Obesity WHO-grade II/III * Blood coagulation disorders, * Coagulation-inhibiting medication other than Aspirin and Clopidogrel, * Invasive measures performed at the affected joint during the previous 12 weeks or planned within the following 12 month, * In the process of applying for pension or disability benefits, * Simultaneous participation in any other clinical trial, * Participation in a clinical trial during the 6 month before inclusion into this trial, * Missing of the written informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Western Ontario and McMaster University Osteoarthritis Index (WOMAC) | week 12 |
Secondary
| Measure | Time frame |
|---|---|
| Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales | month 6 |
| SF-36-questionnaire | week 12 |
| POMS-questionnaire | week 12 |
| Visual Analogue Scales: Pain | week 12 |
| Visual Analogue Scales: Sleep | week 12 |
Countries
Germany
Outcome results
None listed